EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Prognostic Value of Circulating Tumor DNA for Recurrence Risk in Stage III Colorectal Cancer: A Systematic Review and Meta-Analysis

Turkan Aliyeva, Hiba Siddiqui, Julia Natche, Yumna Ahmad Al-Wraikat, Farah Mahzabin Hossain, Imane El-Amri

Clinical Colorectal Cancer · 2025

DOI: 10.1016/j.clcc.2025.10.004 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Colorectal Cancer, 2025. Verfasst von Turkan Aliyeva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Koç University Hospital, Istanbul, Turkey. Electronic address: drturkanaliyeva@gmail.com. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Circulating Tumor DNA, Neoplasm Recurrence, Local, Biomarkers, Tumor. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for minimal residual disease (MRD) detection and recurrence risk stratification in colorectal cancer (CRC). However, its prognostic significance in stage III CRC remains incompletely defined. This meta-analysis aimed to evaluate the association between postoperative ctDNA positivity and recurrence risk in patients with stage III CRC. METHODS: PubMed, Embase, and the Cochrane Library were searched for potentially eligible studies published up to April 2025. Pooled risk ratio (RR) and pooled hazard ratio (HR) were calculated to evaluate recurrence rate and the prognosis of recurrence-free survival (RFS) following CRC surgery and ACT. Meta-analysis was performed using a random-effects model. RESULTS: A total of ten studies involving 2461 stage III CRC patients were included. Postoperative ctDNA positivity was significantly associated with an increased risk of recurrence (RR = 4.39, 95% CI, 3.45-5.58, P < .00001) and a poorer RFS (HR = 6.56, 95% CI, 4.80-8.98, P < .00001). The pooled analysis showed that ctDNA-positive patients had a significantly higher risk of recurrence following ACT (RR = 4.80, 95% CI, 3.17-7.26, P < .00001) and a worse RFS (HR = 10.00, 95% CI, 4.84-20.66, P < .00001). CONCLUSION: Postoperative ctDNA positivity is a strong prognostic marker of recurrence in patients with stage III CRC and could guide individualized surveillance and adjuvant therapy decisions. Further prospective studies are warranted to validate its routine clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCirculating Tumor DNANeoplasm Recurrence, LocalBiomarkers, TumorHumansPrognosisNeoplasm StagingNeoplasm, ResidualRisk AssessmentDisease-Free Survival

Stichwörter der Autor:innen

Circulating tumor DNAcolorectal cancerrecurrence raterecurrence-free survivalstage III

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Internal Medicine, Koç University Hospital, Istanbul, Turkey. Electronic address: drturkanaliyeva@gmail.com.
  • Department of Medical Oncology, Ziauddin Hospital, Karachi, Pakistan.
  • Faculty of Medicine, University of Medicine and Health Sciences, Basseterre, Saint Kitts and Nevis.
  • Faculty of Medicine, University of Jordan, Amman, Jordan.
  • Faculty of Medicine, Shaheed Suhrawardy Medical Hospital, Dhaka, Bangladesh.
  • Department of Medicine and Surgery, Wenzhou Medical University, Wenzhou, China.

Zitieren

APA

Aliyeva, T., Siddiqui, H., Natche, J., Al-Wraikat, Y. A., Hossain, F. M., & El-Amri, I. (2025). Prognostic Value of Circulating Tumor DNA for Recurrence Risk in Stage III Colorectal Cancer: A Systematic Review and Meta-Analysis. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2025.10.004

Vancouver

Aliyeva T, Siddiqui H, Natche J, Al-Wraikat YA, Hossain FM, El-Amri I. Prognostic Value of Circulating Tumor DNA for Recurrence Risk in Stage III Colorectal Cancer: A Systematic Review and Meta-Analysis. Clinical Colorectal Cancer. 2025. doi:10.1016/j.clcc.2025.10.004

BibTeX
@article{Aliyeva2025,
  author = {Aliyeva, Turkan and Siddiqui, Hiba and Natche, Julia and Al-Wraikat, Yumna Ahmad and Hossain, Farah Mahzabin and El-Amri, Imane},
  title = {Prognostic Value of Circulating Tumor DNA for Recurrence Risk in Stage III Colorectal Cancer: A Systematic Review and Meta-Analysis},
  journal = {Clinical Colorectal Cancer},
  year = {2025},
  doi = {10.1016/j.clcc.2025.10.004}
}
Kostenlos starten →